Francesco Di Berardino
Biographic Data
| ID | 9022253 |
|---|---|
| NAME | Francesco Di Berardino |
| GIVEN NAMES | Francesco |
| FAMILY NAME | Di Berardino |
| SIGNATURE | DI BERARDINO F |
| AFFILIATIONS | Università Cattolica del Sacro Cuore |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Pre-emptive pharmacogenetic testing in Italy
Background: Pre-emptive pharmacogenetic (PGx) testing involves identifying genetic variants associated with drug response before prescribing medication, with the aim of guiding drug selection or dosing to reduce adverse reactions and improve outcomes. Despite decreasing costs and the growing feasibility of multi-gene panels, implementation of pre-emptive PGx testing remains limited in Italy. This study aimed to evaluate the potential impact of pr…
Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees
Background: Migrants and refugees in Europe carry a disproportionate burden of chronic hepatitis B and C and face barriers accessing health systems. Community-based interventions can improve screening, prevention, and care, yet no framework exists to track their performance. This study aimed to generate a consensus set of indicators for monitoring and evaluating such interventions. Methods: A scoping review of PubMed from January 2005 to June 202…
No prominent works on this page.
Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees
Background: Migrants and refugees in Europe carry a disproportionate burden of chronic hepatitis B and C and face barriers accessing health systems. Community-based interventions can improve screening, prevention, and care, yet no framework exists to track their performance. This study aimed to generate a consensus set of indicators for monitoring and evaluating such interventions. Methods: A scoping review of PubMed from January 2005 to June 202…
Pre-emptive pharmacogenetic testing in Italy
Background: Pre-emptive pharmacogenetic (PGx) testing involves identifying genetic variants associated with drug response before prescribing medication, with the aim of guiding drug selection or dosing to reduce adverse reactions and improve outcomes. Despite decreasing costs and the growing feasibility of multi-gene panels, implementation of pre-emptive PGx testing remains limited in Italy. This study aimed to evaluate the potential impact of pr…
MEDLINE (2 works) · Biosimilars and Bioanalytical Methods (1 work) · Dosing (1 work) · Genetic testing (1 work) · Genomics and Rare Diseases (1 work) · Hepatitis B (1 work) · Hepatitis C (1 work) · Hepatitis C virus research (1 work) · Hepatitis Viruses Studies and Epidemiology (1 work) · Migration, Health and Trauma (1 work)